NEW YORK (GenomeWeb) – Foundation Medicine today reported a sharp increase in preliminary revenue for the fourth quarter and full year 2015.

The company projects approximately $26.1 million in fourth quarter revenues, up 39 percent from $18.7 million in Q4 2014, and $93.2 million in full-year revenues, up 53 percent from $61.1 million in 2014. Analysts had estimated Q4 earnings of about $25 million for the company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.